Form 4 · Filed Jul 17, 2026, 09:36 PM UTC
ONC/BeOne Medicines Ltd.
OYLER JOHN — Chief Executive Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
11 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jul 17, 2026 | M | other | 64,628 | $120 | $7,752,775 | 64,628 |
| Jul 17, 2026 | S | sell | 1,440 | $305 | $439,486 | 63,188 |
| Jul 17, 2026 | S | sell | 597 | $307 | $183,258 | 62,591 |
| Jul 17, 2026 | S | sell | 680 | $309 | $210,157 | 61,911 |
| Jul 17, 2026 | S | sell | 4,833 | $310 | $1,500,015 | 57,078 |
| Jul 17, 2026 | S | sell | 5,543 | $311 | $1,726,218 | 51,535 |
| Jul 17, 2026 | S | sell | 35,829 | $312 | $11,184,911 | 15,706 |
| Jul 17, 2026 | S | sell | 14,915 | $313 | $4,671,198 | 791 |
| Jul 17, 2026 | S | sell | 740 | $314 | $232,597 | 51 |
| Jul 17, 2026 | S | sell | 51 | $315 | $16,068 | 0 |
| Jul 17, 2026 | M | other | 840,164 | — | — | 441,870 |
Source: SEC EDGAR raw filing ↗ · Accession 0001042047-26-000015